The Metabolic Vulnerability Index (MVX) is a novel biomarker reflecting inflammation and metabolic dysregulation, yet its relationship with chronic kidney disease (CKD) in dysglycemic populations remains unestablished. This study aimed to examine the associations of baseline and longitudinal MVX with incident CKD in people with dysglycemia.